Title: The Addiction Severity Index ASI Across Cultures
1The Addiction Severity Index (ASI) Across Cultures
2005 NIDA International ForumJune 17th, 2005
Workshop II - The Ireland Room B Thanks to
NIDA Steve Gust Erin Winstanley
2The Addiction Severity Index (ASI) Across Cultures
Todays Presenters
3Nasser Loza, Egypt
- Selection, Modification and Inter-rater
Reliability on the use of the ASI in Egypt - Sample Adult Inpatient Hospital Program in Cairo
4Gerasimos Papanastasatos, Greece
- Elaborating and using the ASI across different
national realities and treatment conditions The
EuropASI in Greek Treatment Programmes - Sample Adults in 6 Drug-Free Therapeutic
Communities in Greece
5Richard Isralowitz, Israel
- Understanding the Israeli addict population ASI
profiles of former Soviet Union and native
Israeli opiate abusers - Sample Adults in detoxification, day treatment
and methadone maintenance programs
6Debra Wilson Pauline Murnin, Ireland
- Incorporating the ASI Exploring assessment and
outcomes in a residential treatment facility in
Northern Ireland - Sample Adult Residential Treatment Facility in
Northern Ireland
7Flavio Pechansky, Brazil
- The Brazilian experience on the implementation of
the ASI where are we right now? - Sample Adult Cocaine Abusers _at_ HIV clinics in
Brazil and a Validity Study of the ASI 6
8Richard Rawson, USA
- Experiences using the ASI in different countries.
- and
9Deni Carise, USA
- ASI International Use and Data from 10 Countries
10Introduction
Introduction
The ASI has been translated and modified for use
in many countries.
In addition to those presenting here, researchers
and clinicians in the following countries have
used the ASI
11Countries
Introduction
Thailand Scotland Hungary Ukraine The
Netherlands Sweden Iran Pakistan Spain Italy
Belgium Canada The Caribbean Chile Guatemala
Morocco Tunisia Portugal Russia Norway
12Denis Presentation
Introduction
Today, data are presented from the US Drug
Evaluation Network System and various samples
in Belgium Brazil Greece Ireland It
aly Norway Russia Scotland Sweden
13Data Sets
Caution! No Comparisons!
14Data Sets
Introduction
USA Deni Carise A. Thomas McLellan 8,479
patients from 14 inpatient/ residential, 4
methadone maintenance and 18 out-patient
treatment programs Brazil Flavio Pechansky
Felix Kessler 193 cocaine-dependent clients
from 3 HIV Clinics
15Data Sets
Introduction
Greece Gerasimos Papanastasatos Erianna
Daliani 500 clients from 4 residential and 2
OP programs Ireland Debra Wilson Pauline
Murnin 162 clients from 1 inpatient program
16Data Sets
Introduction
Belgium1 Joke De Wilde 117 Clients from 4
adult residential drug-free TCs Belgium2
Veerle Raes 3,712 clients from a large
drug addiction treatment program
17Data Sets
- Italy Joke De Wilde
- 101 clients from 5 adult residential
- drug-free TCs
- Norway Edle Ravndal
- 482 clients from 10 IP, 4 MM, 3 OP youth
and 4 youth collectives. - Russia Evgeny Krupitsky
- 332 clients from 1 adult hospital detox
treatment program.
18Data Sets
- Scotland Rowdy Yates
- 134 clients from 1 adult OP drug treatment
program. - Sweden Jonas Larsson, David Oberg Bjorn
Sallmen - 201 prisoners from 16 SA prison-based
treatment programs
19Data Sets
Comparisons (Just for Fun)
20Data Presented
- Age
- Gender
- Alcohol Drug Composite scores
- Days heavy drinking
- Days used marijuana
- Days used cocaine
21Data Presented
- Medical, Psychiatric, Family and Legal
- Composite Scores
- Days problems
- Days conflicts
- Percent reporting symptoms
- Illegal behavior
- Employment variables
22International Data
23International Data Drug Alcohol
24International Data Medical Psychiatric
25International Data Family Legal
26Larger Belgium Data Set
- Belgium2 Veerle Raes
- Data collected 1998 - 2004
- 3,712 interviews
- 383 Inpatient 3,329 Outpatient
- All collected from a large illegal drug
addiction treatment program (may
under-represent alcohol use).
27USA vs. Belgium Data by Modality
28USA vs. Belgium Data by Modality
29 Conclusions
NONE
30 Conclusions
Data presented just for discussion - No
conclusions please! Data were collected from too
many different locations (prisons, HIV clinics,
in patient, outpatient treatment programs) and
from too many different samples (opiate only
users, primary alcohol users, an all inpatient
sample, an outpatient only sample, etc.) for
valid comparisons to be made.
31 Limitations
LOTS
32 The End
Thank You!